To evaluate our NAFLD rat model and the effects of CHLZT, we detected the levels of TG, TC, HDL-C, LDL-C, ALT, AST, and insulin in the model rats (Figure 1). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.